Mahendra Shah

Insider Reports History

Location
Houston, TX
Signature
/s/ Andrew Fisher, Attorney-in-fact for Mahendra Shah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mahendra Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verona Pharma plc Director Ordinary Shares 0 $0 $106.71 Oct 7, 2025 Direct
Verona Pharma plc Director Restricted Share Units 96K Apr 25, 2025 Direct
Verona Pharma plc Director Restricted Stock Units 72K Aug 1, 2025 Direct
Bolt Biotherapeutics, Inc. Director Stock Option (Right to Buy) 22K Jun 12, 2024 Direct
IMPEL PHARMACEUTICALS INC Director Stock Option (right to buy) 13.2K Jun 16, 2023 Direct
Verona Pharma plc Director Restricted Share Unit 0 Oct 7, 2025 Direct
Verona Pharma plc Director Share Options (Right to Buy) 0 Oct 7, 2025 Direct

Insider Reports Filed by Mahendra Shah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRNA Verona Pharma plc Oct 7, 2025 8 $0 4 Oct 8, 2025 Director
VRNA Verona Pharma plc Aug 1, 2025 3 -$47.4K 4 Aug 5, 2025 Director
VRNA Verona Pharma plc Apr 25, 2025 1 $0 4 Apr 29, 2025 Director
BOLT Bolt Biotherapeutics, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
VRNA Verona Pharma plc Apr 29, 2024 1 $0 4 Apr 30, 2024 Director
IMPL IMPEL PHARMACEUTICALS INC Jun 16, 2023 1 $0 4 Jun 20, 2023 Director
BOLT Bolt Biotherapeutics, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director
VRNA Verona Pharma plc Apr 28, 2023 1 $0 4 Apr 28, 2023 Director
IMPL IMPEL PHARMACEUTICALS INC Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
BOLT Bolt Biotherapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 10, 2022 Director
VRNA Verona Pharma plc Apr 28, 2022 1 $0 4 Apr 29, 2022 Director
BOLT Bolt Biotherapeutics, Inc. Mar 24, 2022 1 $0 4 Mar 28, 2022 Director
VRNA Verona Pharma plc Aug 9, 2021 1 $0 4 Aug 10, 2021 Director
IMPL IMPEL NEUROPHARMA INC Jul 11, 2021 1 $0 4 Jul 13, 2021 Director